United States of America, ex rel. Dr. Joshu Raiten v. Korunda Medical, LLC (d/b/a Korunda Pain Management Center), and Dr. Zdenko Korunda

District Court, M.D. Florida·Decided July 11, 2026·No. 2:19-cv-00028·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA FORT MYERS DIVISION

UNITED STATES OF AMERICA, ex rel. DR. JOSHU RAITEN,

Plaintiff/Counter-Defendant,

v. Case No.: 2:19-cv-28-SPC-NPM

KORUNDA MEDICAL, LLC (d/b/a Korunda Pain Management Center), and DR. ZDENKO KORUNDA,

Defendants/Counter- Plaintiffs.

OPINION AND ORDER Before the Court is Plaintiff/Counter-Defendant Dr. Joshu Raiten’s (“Relator”) motion to dismiss Defendants/Counter-Plaintiffs Korunda Medical, LLC (d/b/a Korunda Pain Management Center) (“Practice”), and Dr. Zdenko Korunda’s (“Dr. Korunda” and jointly, “Defendants”) amended counterclaim. (Doc. 65). Defendants responded in opposition. (Doc. 77). For the below reasons, the Court grants the motion. Background This is a qui tam action brought under the False Claims Act, 31 U.S.C. § 3729 et seq. (“FCA”). Relator is a physician who Defendants employed from February 1, 2016, until July 8, 2018. When Relator began his employment with Defendants, he received a $25,000 signing bonus (“Signing Bonus”) per his employment agreement. The employment agreement specified if Relator’s

employment terminated for “any reason” within three years, he had to return the Signing Bonus. The Practice is a limited liability company established in 2007 by Dr. Korunda. It provides primary medical care, physical therapy, and pain management services.

Relator alleges that Defendants engaged in a multifaceted scheme to defraud Medicare and Medicaid. According to Relator, Defendants falsified patient records by fabricating anxiety and depression diagnoses for patients. Defendants used these false diagnoses to justify billing for monthly urine

testing, which proved lucrative.1 Additionally, Defendants submitted medical records falsely indicating they performed nerve block procedures on patients, rather than the less lucrative joint injections they actually performed. The fraud purportedly did not stop there. Relator alleges that the

Practice “funneled” patient referrals to a lab and physical therapy clinic Dr. Korunda owned, thereby increasing the amount of fraudulent services billed. (Doc. 61 ¶¶ 46–48, 50–53). Further, Relator alleges Dr. Korunda told him that because he is “capped at ancillary income,” he pays any excess income to his

wife (who is not employed at the Practice) by, inter alia, issuing payments to a

1 The amended complaint alleges that the frequency of urine tests allowed to be billed to Medicare and Medicaid depends on a patient’s risk level for narcotics abuse. (Doc. 61 ¶ 37). non-profit she runs. (Id. ¶¶ 66–69). On top of this, Defendants billed Medicare and Medicaid for services Dr. Korunda did not personally render or supervise,

yet falsely represented that he had.2 Finally, Dr. Korunda failed to have licensed personnel present for procedures to save money. This made billing Medicare or Medicaid for the procedure improper and put patients at risk. (Id. ¶¶ 90–96). Defendants falsified “hundreds, if not thousands, of medical

records” to perpetuate the scheme. (Id. ¶ 99). Dr. Korunda allegedly boasted about the fraud scheme to Relator and ordered him to participate, calling it the “path to partnership” at the Practice. (Id. ¶ 56). Relator “consistently objected to and refused to partake in the

Defendants’ fraud.” (Id. ¶ 101). Dr. Korunda allegedly disciplined Relator for his objections. Relator describes making specifically forceful objections in December 2017 and January 2018 that he would not participate in what he viewed to be fraud. On February 9, 2018, Defendants provided written notice

they intended to terminate Relator’s employment contract. Relator’s employment officially ended on July 8, 2018. Relator filed his qui tam complaint on January 16, 2019, under seal. (Doc. 1). On December 2, 2025, the United States filed a notice indicating it

2 Dr. Korunda frequently traveled to Croatia, his native country. Relator allegedly observed medical records indicating Dr. Korunda performed or supervised services at the Practice while he was out of the United States. (Doc. 61 ¶ 85). would not intervene in this action, and the Court unsealed the complaint. (Docs. 47, 48). Under 31 U.S.C. § 3730(b)(1), Relator exercised his right to

prosecute the case on behalf of the United States. Relator brings three claims against Defendants: violation of the FCA for submitting false claims, 31 U.S.C. § 3729(a)(1)(A) (Count I), violation of the FCA making false records and/or statements in connection with false claims,

31 U.S.C. § 3729(a)(1)(B) (Count II), and violation of the anti-retaliation provision of the FCA, 31 U.S.C. § 3730(h) (Count III). Defendants answered the complaint and filed a counterclaim. (Doc. 62). Defendants bring a breach of contract counterclaim against Relator to recover

the Signing Bonus. Defendants allege that Relator’s employment contract obligated him to return the Signing Bonus if his employment terminated within the first three years “for any reason.” (Id. ¶ 19). Defendants allege Relator breached the agreement by failing to return the Signing Bonus upon

being terminated in July 2018, less than three years after his employment began. Relator moves to dismiss the counterclaim under Federal Rule of Civil Procedure 12(b)(6), arguing that the claim is time-barred. Legal Standard

A motion to dismiss a counterclaim under Federal Rule of Civil Procedure 12(b)(6) “is evaluated in the same manner as a motion to dismiss a complaint.” Whitney Info. Network, Inc. v. Gagnon, 353 F. Supp. 2d 1208, 1210 (M.D. Fla. 2005) (citation omitted). A district court should dismiss a claim where a party fails to plead facts that make the claim facially plausible. See

Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). A claim is facially plausible when a court can draw a reasonable inference, based on facts pled, that the opposing party is liable for the alleged misconduct. See Ashcroft v. Iqbal, 556 U.S. 662, 668 (2009). When considering a Rule 12(b)(6) motion, the

reviewing court must accept all factual allegations in the complaint as true and view them in a light most favorable to the plaintiff. See Iqbal, 556 U.S. at 678. Analysis Relator argues that Defendants’ counterclaim should be dismissed

because it is barred by the applicable statute of limitations. Defendants’ counterclaim accrued as soon as Relator’s employment ended on July 8, 2018, and he failed to return the Signing Bonus. (Doc. 62 ¶ 25); Multiphone Latin Am. Inc. v. Millicom Int’l Cellular S.A., No. 25-23249-CIV, 2025 WL 2480412,

at (S.D. Fla. Aug. 28, 2025) (“A breach-of-contract claim generally accrues at the time of breach.”). Thus, Relator argues, the statute of limitations expired on July 8, 2023. (Doc. 65 at 11); see Jeunesse, LLC v. LifeWave, Inc., No. 6:15- CV-131-0RI-28, 2015 WL 4911349, at *2 (M.D. Fla. Aug. 17, 2015) (noting the

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America, ex rel. Dr. Joshu Raiten v. Korunda Medical, LLC (d/b/a Korunda Pain Management Center), and Dr. Zdenko Korunda, (M.D. Fla. 2026).

United States of America, ex rel. Dr. Joshu Raiten v. Korunda Medical, LLC (d/b/a Korunda Pain Management Center), and Dr. Zdenko Korunda (United States of America, ex rel. Dr. Joshu Raiten v. Korunda Medical, LLC (d/b/a Korunda Pain Management Center), and Dr. Zdenko Korunda) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
United States v. Amtreco, Inc.
790 F. Supp. 1576 (M.D. Georgia, 1992)
Whitney Information Network, Inc. v. Gagnon
353 F. Supp. 2d 1208 (M.D. Florida, 2005)
Five Percent Nutrition, LLC v. Get Fit Fast Supplements, LLC
391 F. Supp. 3d 1093 (M.D. Florida, 2019)
United States ex rel. Mueller v. Eckerd Corp.
184 F.R.D. 686 (M.D. Florida, 1999)